Approvals/TGA/Deferasirox Juno deferasirox 125 mg dispersible tablet blister pack

Approved

STANDARD

Deferasirox Juno deferasirox 125 mg dispersible tablet blister pack

Juno Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4d8a16f5aa771f51
Product Name: Deferasirox Juno deferasirox 125 mg dispersible tablet blister pack
Artg Id: 306559
Artg Name: Deferasirox Juno 125 mg deferasirox dispersible tablet blister pack
Sponsor: Juno Pharmaceuticals Pty Ltd
Company Detail Path: /organization/juno-pharmaceuticals-pty-ltd
Artg Date: 2019-11-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/7d1e3bddd5435f862aa92b6a66d87acc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/89f751a56ed71b7e73d55ee9dffe5c45.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4d8a16f5aa771f51

Type

Standard